January 30, 2025 — A new paper in JAMA Network Open documents just how dizzy the pace of change in prescribing for obesity care has been in the last seven years. Prescriptions for obesity medicines have doubled. Phentermine prescribing has grown – it’s generic, cheap, and effective. Even now, it accounts for almost half of obesity medicine prescriptions. But […]
November 9, 2024 — The wild ride that has been 2024 in the market for obesity care is not quite over yet. If you want to know exactly how wild this ride has been, take a moment to digest the results that the two leaders in obesity – Eli Lilly and Novo Nordisk – have posted. The sales Lilly […]
October 30, 2024 — November is upon us and thus, so is ObesityWeek 2024 in San Antonio. This has been a year of radical change in the environment for obesity research, prevention, and care. So as we peruse the program for this meeting, it comes across as a year for consolidating the understanding of this disease and transformative options […]
